LigaMimetic

LigaMimetic (specifically LigaMimetic PDL) is a synthetic, bioactive regenerative matrix developed by Geistlich Pharma for use in periodontal surgery. It is designed to mimic the natural extracellular matrix of the periodontal ligament (PDL), providing a structural and biochemical scaffold that supports the recruitment, attachment, and proliferation of PDL cells. The product typically consists of a synthetic hydrogel (such as polyethylene glycol) functionalized with cell-binding peptides (e.g., RGD sequences) that interact with cell-surface integrins. Its primary indication is the treatment of intrabony periodontal defects, where it aims to promote the regeneration of the attachment apparatus—comprising the cementum, periodontal ligament, and alveolar bone—rather than merely facilitating repair via long junctional epithelium. By stabilizing the wound space and providing a biomimetic environment, LigaMimetic facilitates predictable tissue regeneration in complex oral environments.

Brand names

LigaMimetic PDL

Other names

Geistlich LigaMimetic